Year: 2019

Press Release – Paris – 12/12/2019On 11 December 2019, the Bouygues group was presented with the “Grand Prix FAS 2019” award for employee share ownership at the fifteenth FAS awards ceremony. The “Grand Prix FAS de l’Actionnariat Salarié” awards ceremony, organised by FAS (the French federation of employee and former employee shareholders associations) and its partners LHH-Altedia and Amundi, aims to recognise those French companies that contribute actively to the expansion of employee share ownership in France.The award, handed to Bouygues by Pierre-André de Chalendar, Chairman and CEO of the Saint-Gobain group, is the top award amongst the seven given out by the jury. It is awarded to those companies offering their employees long-term and innovative share ownership arrangements.Under the impetus of Francis Bouygues in 1969, the Bouygues...

Communiqué de presse – Paris – 12/12/2019Le 11 décembre 2019, le Groupe Bouygues a reçu le Grand Prix FAS 2019 de l’actionnariat salarié, dans le cadre de la quinzième cérémonie de la FAS. Le Grand Prix FAS de l’Actionnariat Salarié est organisé par la FAS, Fédération Française des Associations d’Actionnaires Salariés et Anciens Salariés, et ses partenaires LHH-Altedia, et Amundi, qui souhaitent récompenser les sociétés françaises participant activement au développement de l’actionnariat salarié.Ce prix, remis à Bouygues par Pierre-André de Chalendar, président-directeur général du groupe Saint-Gobain, est la plus haute distinction parmi les 7 Prix décernés par le jury. Il est attribué aux sociétés qui proposent à leurs salariés des dispositifs d’actionnariat salarié pérennes et innovants.En 1969, le groupe Bouygues lance son programme...

Panevezio statybos trestas AB (PST) has signed the contract for Construction of Office and Residential Complex at Basanaviciaus Str. 10, Vilnius.The cost of the contractual works amounts to EUR 18,5 mln Eur (VAT incl.). The total area of the buildings is 10,058.56 square meters. The project completion is scheduled for the autumn of 2021.More information:Managing DirectorDalius GeseviciusTel.: (+370 45) 505 503

AB ,,Panevėžio statybos trestas“ (PST) pasirašė sutartį dėl administracinių ir gyvenamųjų namų pastatų komplekso Basanavičiaus g. 10, Vilniuje statybos darbų.Sutartyje nurodytų darbų atlikimo kaina  18, 5 mln Eur  (su PVM). Bendras statinių plotas 10058, 56 kv. m. Darbus planuojama baigti 2121 m. rudenį.Daugiau informacijos:Generalinis direktoriusDalius GesevičiusTel.: (8-45) 505 503

IDEX biometrics ASA held an Extraordinary General Meeting on 12 December 2019. 280,274,239 shares or 43% of the capital was represented at the meeting.All resolutions were made as proposed in the notice of the meeting.The EGM resolved to issue 64,574,593 shares in Tranche Two of the private placement disclosed on 18 November 2019. Following the tranche two capital increase, IDEX will have a share capital amounting to NOK 107,698,309.80 divided into 717,988,732 shares at NOK 0.15 nominal value per share.For further information contact:Derek P. D’Antilio, CPAChief Financial OfficerTel: +1 978 273 1344derek.dantilio@idexbiometrics.comErling SvelaVP FinanceTel: +47 4062 1040erling.svela@idexbiometrics.comAbout IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering...

 Share Buyback Transaction Details December 5 – 11, 2019December 12, 2019 – Wolters Kluwer today reports that it has repurchased 328,265 of its own ordinary shares in the period from December 5, 2019, up to and including December 11, 2019, for €21.1 million and at an average share price of €64.13.These repurchases are part of the share buyback program originally announced on February 20, 2019, under which we intended to repurchase shares for up to €250 million during 2019. On November 1, 2019, this program for 2019 was subsequently expanded by €100 million to €350 million.The cumulative amounts repurchased to date under this program are as follows:Share Buyback 2019 For the period starting November 4, 2019, up to and including December 27, 2019, we have engaged a third party to execute €160 million of buybacks on our behalf,...

SCANFIL OYJ        PÖRSSITIEDOTE    12 JOULUKUUTA 2019  KLO 11:00Scanfil Oyj on kansainvälinen elektroniikkateollisuuden sopimusvalmistaja ja järjestelmätoimittaja, jolla on yli 40 vuoden kokemus vaativasta sopimusvalmistustoiminnasta. Scanfil tarjoaa asiakkaiden käyttöön laajan palvelukokonaisuuden, joka ulottuu tuotesuunnittelusta tuotteen valmistukseen, materiaalien hallintaan sekä logistisiin ratkaisuihin. Vertikaalisesti integroitu tuotanto ja kokonaisvaltainen toimitusketju luovat pohjan Scanfilin kilpailuvalteille: nopeudelle, joustavuudelle ja luotettavuudelle.Tyypillisiä Scanfilin valmistamia tuotteita ovat mobiili- ja tietoliikenneverkkolaitteet, automaatiojärjestelmien moduulit, taajuusmuuttajat, hissien ohjausjärjestelmät, analysaattorit, erilaiset peli- ja itsepalveluautomaatit sekä hoitoteknologiaan ja säähavainnointiin...

SCANFIL PLC        STOCK EXCHANGE RELEASE     12 DECEMBER 2019  11:00 A.M.Scanfil is an international contract manufacturer and system supplier for the electronics industry with 40 years of experience in demanding contract manufacturing. Scanfil provides its customers with an extensive array of services, ranging from product design to product manufacturing, material procurement and logistics solutions. Vertically integrated production and a comprehensive supply chain are the foundation of Scanfil’s competitive advantages: speed, flexibility and reliability.Typical Scanfil products include mobile and communications network devices, automation system modules, frequency converters, lift control systems, analysers, various slot and vending machines, and devices related to medical technology and meteorology. Scanfil services are used by numerous...

STOCKHOLM, SWEDEN – December 12, 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) (“Karolinska Development” or the “Company”) today announces that Sino Biopharmaceutical and Chia Tai Resources Limited (together ”Sino Biopharma”) have divested their remaining convertibles equivalent to SEK 85 million in nominal terms to Worldwide International Investments Limited (“Worldwide”). Worldwide has committed to set-off its convertibles by subscribing for shares in the ongoing set-off issue of series B shares to the holders of the Company’s 2015/2019 convertible loan (the “Directed Issue”). To enable Worldwide’s participation in the Directed Issue, the Board of Directors of the Company has resolved that the subscription period for the Directed Issue starting July 8 will be extended to December 16, 2019.Sino Biopharma has divested SEK 85...

STOCKHOLM, SVERIGE – 12 december 2019. Karolinska Development AB (publ) (”Karolinska Development” eller ”Bolaget”) meddelar idag att Sino Biopharmaceutical Limited och Chia Tai Resources Limited (tillsammans ”Sino Biopharma”) har avyttrat sitt återstående konvertibellån motsvarande 85 miljoner kronor i nominellt värde till Worldwide International Investments Limited (”Worldwide”). Worldwide har vidare åtagit sig att kvitta sitt konvertibelinnehav genom att teckna aktier i den pågående riktade nyemissionen av B-aktier till innehavare av Bolagets konvertibel 2015/2019 (”Riktade nyemissionen”). För att möjliggöra Worldwides deltagande i den Riktade nyemissionen har styrelsen för Bolaget beslutat att teckningsperioden för den Riktade nyemissionen med start 8 juli förlängs till och med den 16 december 2019.Sino Biopharma har avyttrat 85 miljoner...